0.30GBP +0.00% (+0.00)
Over 6M: +27.8%
Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.
How much of the revenue is really kept — and what did it take to earn it?
How predictable is the revenue, and how much of it is already committed?
Can the balance sheet absorb a bad year?
Is the business getting bigger, and is it getting more profitable?
As the company reported it, one row per year, straight from the filings.
| Fiscal year | Ends | Revenue |
|---|---|---|
| 2020 | 2020-12-31 | 142,000,000 |
| 2021 | 2021-12-31 | 134,100,000 |
| 2022 | 2022-12-31 | 199,100,000 |
| 2023 | 2023-12-31 | 167,900,000 |
| 2024 | 2024-12-31 | 136,000,000 |
| 2025 | 2025-12-31 | 114,600,000 |
The figures themselves rather than their scores — what somebody looking up PHAR.L on one particular measure came for.
| Ratio | Value |
|---|---|
| cash operating margin | 7.59 |
| current ratio | 4.11 |
| current ratio reported | 4.11 |
| ebit cagr | -34.85 |
| ebit yoy | -86.47 |
| fcf margin | 34.47 |
| interest cover | 3.95 |
| operating margin | 7.59 |
| owner earnings margin | 34.47 |
| revenue growth | -15.74 |
| revenue growth per share | -15.74 |
| roic | 2.82 |
| rule of 40 | -8.14 |
| sbc pct revenue | 0.0 |
This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.
| Figure | Value | XBRL tag | As at |
|---|---|---|---|
| capex | 16,100,000 | PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
2025-12-31 |
| cash | 40,200,000 | CashAndCashEquivalents |
2026-01-01 |
| current assets | 66,200,000 | CurrentAssets |
2026-01-01 |
| current liabilities | 16,100,000 | CurrentLiabilities |
2026-01-01 |
| equity | 283,900,000 | Equity |
2026-01-01 |
| interest expense | 2,200,000 | FinanceCosts |
2025-12-31 |
| ocf | 55,600,000 | CashFlowsFromUsedInOperatingActivities |
2025-12-31 |
| revenue | 114,600,000 | Revenue |
2025-12-31 |
The dashboard puts PHAR.L beside other companies and lets you change what counts: the weight of each dimension, the value that earns a ten, and which of the 61 measures are included at all.